Day: July 20, 2022
BRIDGEVILLE, Pa., July 20, 2022 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that it will report financial results for the second quarter of 2022 on Wednesday, July 27, 2022. In conjunction with the earnings release, the Company will host a conference call at 10:00 a.m. (Eastern) on July 27th. The call will be webcast simultaneously for all interested parties over the Internet.
New Call Dial-In Procedures:
Please click here to pre-register for the conference call and obtain your dial-in number and personal PIN number.
The simultaneous webcast will be available on the Company’s website at www.univstainless.com, and thereafter archived on the website through the end of the third quarter of 2022. Please allow 5 minutes prior to the live webcast to visit the site to download and...
React Gaming commences trading on the OTCQB® Venture Market in the United States
Written by Customer Service on . Posted in Public Companies.
React Gaming Group
React Gaming commences trading on the OTCQBMONTREAL, July 20, 2022 (GLOBE NEWSWIRE) — React Gaming Group Inc. (“React Gaming” or the “Corporation”) (TSXV: RGG, OTCQB: ITMZF) is pleased to announce that it has qualified to trade on the OTCQB® Venture Market (the “OTCQB”) in the United States. The Corporation upgraded to the OTCQB from the Pink® market.
React Gaming begins trading today on OTCQB under the symbol “ITMZF” and investors can find quotes for the Corporation’s common shares on the OTC Markets website. The Corporation’s shares will continue to trade on the TSX Venture Exchange under the symbol “RGG”.
“We are very pleased to be trading on the OTCQB, as it will facilitate trading in our stock for U.S. investors and help expand our retail and institutional base to a larger pool of investors...
Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade
Written by Customer Service on . Posted in Public Companies.
Webinar to be held Thursday, July 28th @ 10:30am EDT
ATLANTA, July 20, 2022 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that, in the wake of the overturn of Roe v. Wade, it will host a key opinion leader (KOL) event to discuss FemBloc, the Company’s proprietary, first-of-its kind medical solution for permanent birth control, on Thursday, July 28, 2022 at 10:30am Eastern Daylight Time.
The webinar will feature a presentation from KOL, Paul D. Blumenthal, MD, MPH, Professor of Obstetrics and Gynecology at The Stanford University Medical Center, who will discuss the unmet need for women seeking permanent birth control options....
Marimaca Continues to Improve Confidence in the High-Grade Core of the MOD: MAR-68 EXT intersects 384m at 0.64% CuT from 2m; ATR-112 intersects 118m at 0.96% CuT from 4m
Written by Customer Service on . Posted in Public Companies.
Figure 1
Plan View of Infill Drilling Results, Planned Holes and MOD PEA Pit ShellVANCOUVER, British Columbia, July 20, 2022 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce further results from the 2022 infill and extensional drilling campaign. Results reflect a total of 4,068m across 20 drill holes.
The drilling intersected broad zones of near-surface green copper oxide mineralization in 19 of the 20 drill holes. Drilling was focused on infilling the higher-grade central core of the MOD, and the MAMIX depth-extension zone discovered in the 2021 drilling campaign (see press release dated October 14, 2021). As with previous results (see announcements dated June 13, 2022, May 19, 2022, and May 10, 2022), drilling continues to demonstrate the excellent thickness and...
Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe
Written by Customer Service on . Posted in Public Companies.
Agreement Highlights Momentum in Onshoring of Contract Manufacturing Projects to U.S. from Sites Around the World
SAN DIEGO and GAINESVILLE, Ga., July 20, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it has been selected to provide CDMO services to support the ongoing clinical development of a novel drug candidate in Europe. The compound is an oral solid dose anti-viral therapy product approved for the prevention and treatment of human immunodeficiency virus (HIV) in select countries in Europe and Societal’s work is focused on supporting the expansion of the product’s indications.
Under terms of the...
Blue Sky Distribution Supports Ecommerce Hypergrowth with Descartes Solution
Written by Customer Service on . Posted in Public Companies.
ATLANTA, July 20, 2022 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that New Mexico-based grocery and convenience item distributor Blue Sky Distribution is managing rapid ecommerce growth and extreme peaks in order volumes using the Descartes OzLink™ Mobile Warehouse solution. Fully integrated with NetSuite ERP, the Descartes solution helped Blue Sky to scale fulfillment while leveraging granular operational data to optimize returns management, sales forecasting and warehouse staff retention initiatives.
“We pride ourselves on providing customers with quality products and premium services—delivering goods on time and maintaining high fill rates to satisfy customer expectations,” said Robert Poole, CEO and President, Blue Sky...
Mercury to provide radar testing systems to Leonardo
Written by Customer Service on . Posted in Public Companies.
ANDOVER, Mass., July 20, 2022 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical technologies for aerospace and defense, announced it has been selected by Leonardo UK to provide multiple radar test and simulation systems to factory-test Leonardo’s innovative E-scan radar. The Company will also provide additional systems to support, maintain and prepare deployed aircraft for specific mission profiles using Mercury’s flexible programming environment. This contract follows a previous one awarded by Leonardo to Mercury in 2019 to design and manufacture the next generation of processing technology for Leonardo’s E-Scan radar being developed in the UK.
Why It MattersNew radar technologies, such as synthetic aperture radar (SAR) imaging, have dramatically increased the complexity...
Cinema Camera Market Size [2022-2029] | Industry Share, Revenue, Key Players, CAGR, Demand and Sales Forecast
Written by Customer Service on . Posted in Mergers And Acquisitions.
Companies Profiled in the Cinema Camera Market Research Report are Sony Electronics Inc., Hitachi Kokusai Electric America, Ltd., Canon U.S.A., Inc., FUJIFILM Corporation., Blackmagic Design Pty. Ltd., Panasonic Corporation, ARRI AG, and Red
Pune, India, July 20, 2022 (GLOBE NEWSWIRE) — Increasing number of production houses and broadcasters is boosting the global cinema camera market. The above information was shared by Fortune Business Insights in a report, titled “Cinema Camera Market Size, Share and Global Trend By Sensors type (CMOS & CCD), By Lens Type (EF Mount & Pl Mount), By Video Resolution (4K / 8K Resolution & Full HD Resolution), and Geography Forecast till 2029.” Cinema cameras were initially used for the television industry to capture gesture and electronic motion pictures. However, cinema camera is...
Akari Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Pipeline Progress
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Four patients have been enrolled in the Phase 3 Part A clinical trial of nomacopan in severe pediatric hematopoietic stem cell transplant related (HSCT) thrombotic microangiopathy (TMA); the Part A study is enrolling seven patients
Ten of the clinical trial sites across the U.S., Germany, and the Netherlands are now opened and screening has begun for the placebo-controlled ARREST-BP Phase 3 Part A study of investigational nomacopan in bullous pemphigoid (BP) that has a recruitment goal of 48 patients; Akari continues to open clinical trial sites
Significant progress has been made in the pre-clinical work on tolerability and extended dose interval of long-acting PAS-nomacopan for geographic atrophy (GA) in dry age-related macular degeneration (dAMD); advances PAS-nomacopan on the pathway to potential IND/IMPD
Appointment of accomplished...
Form 8.3 – [BIFFA PLC – 19 07 2022] – CGWL
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
BIFFA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position held/dealing...